Specific Asparagine-Linked Glycosylation Sites Are Critical for DC-SIGN- and L-SIGN-Mediated Severe Acute Respiratory Syndrome Coronavirus Entry
- 1 November 2007
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 81 (21) , 12029-12039
- https://doi.org/10.1128/jvi.00315-07
Abstract
Severe acute respiratory syndrome (SARS) is caused by a newly emerged coronavirus (CoV) designated SARS-CoV. The virus utilizes angiotensin-converting enzyme 2 (ACE2) as the primary receptor. Although the idea is less clear and somewhat controversial, SARS-CoV is thought to use C-type lectins DC-SIGN and/or L-SIGN (collectively referred to as DC/L-SIGN) as alternative receptors or as enhancer factors that facilitate ACE2-mediated virus infection. In this study, the function of DC/L-SIGN in SARS-CoV infection was examined in detail. The results of our study clearly demonstrate that both proteins serve as receptors independently of ACE2 and that there is a minimal level of synergy between DC/L-SIGN and ACE2. As expected, glycans on spike (S) glycoprotein are important for DC/L-SIGN-mediated virus infection. Site-directed mutagenesis analyses have identified seven glycosylation sites on the S protein critical for DC/L-SIGN-mediated virus entry. They include asparagine residues at amino acid positions 109, 118, 119, 158, 227, 589, and 699, which are distinct from residues of the ACE2-binding domain (amino acids 318 to 510). Amino acid sequence analyses of S proteins encoded by viruses isolated from animals and humans suggest that glycosylation sites N227 and N699 have facilitated zoonotic transmission.Keywords
This publication has 51 references indexed in Scilit:
- Structural Basis of Neutralization by a Human Anti-severe Acute Respiratory Syndrome Spike Protein Antibody, 80RJournal of Biological Chemistry, 2006
- DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome CoronavirusJournal of Virology, 2004
- Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoproteinVirology, 2004
- Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirusProceedings of the National Academy of Sciences, 2004
- DC-SIGN Interactions with Human Immunodeficiency Virus Type 1 and 2 and Simian Immunodeficiency VirusJournal of Virology, 2001
- Spike Glycoprotein Cleavage Recognition Site Analysis of Infectious Bronchitis VirusPublished by JSTOR ,2001
- DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in transProceedings of the National Academy of Sciences, 2001
- Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cellsProceedings of the National Academy of Sciences, 1997
- Molecular characterization of the S protein gene of human coronavirus OC43Journal of General Virology, 1993
- Deduced sequence of the bovine coronavirus spike protein and identification of the internal proteolytic cleavage siteVirology, 1990